Interleukin (IL)-10 is an important regulatory cytokine that can modulate excessive immune mediated injury. Several distinct cell types have been demonstrated to produce IL-10, including most recently CD8 + cytotoxic T lymphocytes (CTLs) responding to respiratory virus infection. Here we report that CD4 + T cell help in the form of IL-2 is required for IL-10 production by CTLs, but not for the induction of CTL effector cytokines. We show that IL-2 derived from CD4 + helper T cells cooperates with innate immune cell-derived IL-27 to amplify IL-10 production by CTLs through a Blimp-1-dependent mechanism. These findings reveal a previously unrecognized pathway that coordinates signals derived from innate and helper T cells to control the production of a regulatory cytokine by CTLs during acute viral infection.
A r t i c l e s IL-10 is an important anti-inflammatory cytokine that can suppress both innate and adaptive immune responses to infectious agents or autoantigens 1, 2 . Certain pathogens exploit IL-10 to suppress the host response and establish chronic infection 2 . However, during acute infections that induce strong inflammatory responses, IL-10 often acts beneficially to moderate excessive inflammation 2 .
Although various innate and adaptive immune cell types have been identified as IL-10 producers 3 , there is increasing evidence that effector T cells are an important source of IL-10, especially during certain parasitic and viral infections [4] [5] [6] . Thus, the cells that often produce or enhance inflammation during infection can regulate their own proinflammatory activity through IL-10 production 7 . However, the cellular and molecular mechanisms controlling in vivo IL-10 expression in T cells, and particularly in effector T cells, are imperfectly understood. In certain regulatory T-cells, stimuli such as dexamethasone plus vitamin D3, IL-27, IL-21, transforming growth factor-β and aryl hydrocarbon receptor ligands, as well as IL-10 itself, promote IL-10 production 3, [8] [9] [10] [11] [12] , and IL-27, IL-21 and IL-12 are reported to augment IL-10 production by CD4 + effector T cells [13] [14] [15] [16] [17] . However, despite the many signals identified as promoting IL-10 production by T cells, the in vivo significance and relative contribution of these signals is poorly defined. Similarly, the intracellular signaling intermediates activated by these IL-10-promoting signals in T cells remain underexplored, although the transcription factors STAT3 and c-Maf and recently the aryl hydrocarbon receptor have been implicated in controlling IL-10 gene expression in CD4 + T cells 3, 11, 12 .
Antiviral CD8 + CTLs are a chief producer of IL-10 in the respiratory tract during influenza infection 6 . CTL-derived IL-10 is critical for preventing excess inflammation during immune-mediated virus clearance 6 . In this report, we investigate the signals necessary to drive the production of IL-10 by CTLs in the infected respiratory tract.
Our data identify an interplay between products of helper T cells and infiltrating innate immune cells in shaping the function of antiviral CTLs at the site of infection.
RESULTS

IL-10 + CTL development requires IL-27 and helper T cells
To investigate the mechanisms regulating IL-10 production by antiviral CTLs during influenza infection, we first examined whether interferon-γ (IFN-γ) is required, as the IL-10-producing CTLs coexpress IFN-γ ( Supplementary Fig. 1 ). IFN-γ was dispensable for the induction of IL-10-producing CTLs (Supplementary Fig. 1) . Similarly, although IL-12 is important for inducing IL-10-producing T cells in some settings 17 , it was not required for the induction of IL-10-producing CTLs during influenza infection, as CD8 + T cells from Il12a −/− mice, null for the p35 subunit of the cytokines IL-12 and IL-35 (ref. 18 ) could produce IL-10 ( Fig. 1a) . IL-27 induces the development of IL-10-producing CD4 + T cells 3 ; therefore, we examined the role of IL-27 in controlling the induction of IL-10-producing CTLs during influenza infection. Influenza infection induced IL-27 gene expression in the respiratory tract ( Supplementary  Fig. 2) . We then infected IL-27 subunit-deficient Ebi3 −/− mice (which lack both IL-27 and IL-35; ref. 18 ) with influenza and measured IL-10 production by influenza-specific CTLs. EBI-3 deficiency did not affect the induction of IFN-γ-producing CTLs, but it substantially impaired the induction of IL-10-producing CTLs in both draining lymph nodes (the mediastinal lymph nodes, MLNs) and the infected lungs (Fig. 1b,c) . Consistent with the impaired production of IL-10 by CTLs, Ebi3 −/− mice showed impaired IL-10 release in the airway and enhanced pulmonary inflammation during influenza infection (Supplementary Fig. 3 ). The induction of IL-10producing CD4 + T cells by IL-27 depends on IL-21 signaling 10 ;
A r t i c l e s however, the induction of IL-10-producing CTLs during influenza infection was intact in mice lacking IL-21 receptor (Fig. 1d) .
The absence of IL-27 did not completely abrogate IL-10-producing CTLs, suggesting that other signals contribute to the induction of these cells. Release of IL-10 in vivo depends on both CD8 + and CD4 + T cells 6 , suggesting a possible role of CD4 + T cells in the induction of IL-10-producing CTLs. We thus eliminated both IL-27 and CD4 + T cells in vivo and examined the induction of IL-10-producing CTLs upon influenza infection. Depletion of CD4 + T cells, together with EBI-3 deficiency, almost completely abrogated the induction of IL-10producing CTLs (Fig. 1e,f) . Elimination of CD4 + T cells and IL-27 also compromised the production of IL-10 at the single-cell level ( Fig. 1g ) in the few remaining IL-10 + CTLs (Fig. 1g) . Taken together, these data suggest that the induction of IL-10-producing CTLs during influenza infection depends on the presence of both IL-27 and helper T cells, but is independent of IL-12, IL-21, IL-35 and IFN-γ.
Helper T cells selectively induce IL-10 + CTL development
The finding that the induction of IL-10-producing CTLs in vivo required the presence of CD4 + T cells raised the possibility that CD4 + T cell 'help' is required for physiologic CTL responses to influenza infection. We therefore examined the role of CD4 + T cells in the accumulation and differentiation of CTLs in the respiratory tract during influenza infection. The depletion of CD4 + T cells severely impaired the production of IL-10, but not IFN-γ or tumor necrosis factor (TNF), by CTLs ( Fig. 2a,b) . These data agree with reported findings 19, 20 and suggest that CD4 + T cell help is minimally required for the differentiation and accumulation of CTLs. CD4 + T cell depletion at various time points impaired the development of IL-10-producing CTLs, even at 6 days after infection (d.p.i.)-that is, when T cells have entered the infected lungs-suggesting that CD4 + T cells are able to help CD8 + T cells in the lung as well as in the MLNs (Supplementary Fig. 4) .
To further confirm the effect of CD4 + T cell depletion, we infected H2-Ab1 −/− (major histocompatibility complex (MHC) type II null) mice, which lack CD4 + T cells, with influenza and found that CD8 + T cells from H2-Ab1 −/− mice were likewise impaired in IL-10 but not IFN-γ or TNF production ( Fig. 2c) . The absence of CD4 + T cells only minimally affected the expression of the cytolytic molecule granzyme B by CTLs ( Supplementary Fig. 5 ). We next directly examined the role of CD4 + T cell help in the in vivo induction of IL-10-producing CTLs by using IL-10 reporter (Vert-X) mice 21 . Il10 gene expression in CTLs was primarily restricted to the site of infection, the lungs ( Supplementary  Fig. 6 ). Notably, the depletion of CD4 + T cells significantly impaired the development of IL-10-expressing cells among both total lung-infiltrating CD8 + T cells and gated influenza antigen-specific cells ( Fig. 2d and Supplementary Fig. 6 ). We also bred Vert-X mice to H2-Ab1 −/− mice and infected Vert-X H2-Ab1 −/− mice with influenza. Compared to the influenza-specific CD8 + T cells from littermate Vert-X H2-Ab1 +/− mice, influenza-specific T cells from Vert-X H2-Ab1 −/− mice had diminished IL-10-expressing cell numbers ( Fig. 2e ) and IL-10 expression intensity at the single-cell level (Supplementary Fig. 7 ). We also verified in vivo that CD4 + T cell help was not required for the induction of IFN-γ-expressing cells using IFN-γ-enhanced yellow fluorescent protein (eYFP) reporter (Yeti) mice, which were constructed similarly to the Vert-X mice ( Fig. 2f and Supplementary Fig. 8 ) 22 . Collectively, these data suggest that CD4 + T cell help is critical for inducing an optimal anti-inflammatory cytokine profile (that is, IL-10 production) but not for the activation and differentiation of the effector features of influenza-specific CTLs in vivo.
IL-2 provides help for IL-10 + CTL development
To identify the molecule(s) that mediate the help from CD4 + T cells, we developed an in vitro T cell-dendritic cell (DC) culture system. We labeled influenza hemagglutinin-specific CD8 + T cell receptor (TCR) transgenic T cells (CL-4) with the cytosolic dye CFSE and 
Ebi3
-/-+ α-CD4 stimulated them with influenza-infected DCs in the absence or presence of hemagglutinin-specific CD4 + TCR transgenic T cells (TS-1). CL-4 T cells stimulated with influenza-infected DCs expanded and expressed IFN-γ but failed to produce IL-10 ( Fig. 3a) . However, when CD4 + TS-1 cells were included in the culture, CL-4 cells acquired the ability to produce IL-10. Notably, all IL-10-producing cells were also IFN-γ + (Supplementary Fig. 9 ). These data recapitulated our in vivo findings that CD4 + T cells were able to provide the help to CD8 + T cells to induce the development of IL-10-producing CTLs.
IL-2 is one of the principal cytokines produced by CD4 + T cells and has been shown to support expansion and differentiation of CTLs 23, 24 . We therefore evaluated the effect of IL-2 on IL-10 expression by CL-4 T-cells in the T cell-DC culture system. Neutralization of mouse IL-2 completely blocked the induction of IL-10-producing CL-4 CTLs in vitro but only modestly affected cell proliferation and IFN-γ production by CTLs ( Fig. 3a) . Notably, addition of human IL-2 to cultures reversed the effects of mouse IL-2 neutralization (Fig. 3a) . In companion experiments, we purified CD8 + T cells from double transgenic 
hIL-2 IL-2 (ng ml Fig. 3b and Supplementary  Fig. 10a ). We further established that CD4 + T cells were the principal IL-2-producing cells in the culture (Fig. 3c) . IL-2 is therefore likely to be the primary molecule derived from CD4 + T cells that provides help to CD8 + T cells to drive the development of IL-10-producing CTLs. Our finding ( Supplementary Fig. 4 ) that depletion of CD4 + T-cells as late as 6 d.p.i. inhibited IL-10 production by CTLs in the infected lungs suggested that CD4 + T cell-derived IL-2 may not only act at the induction phase of the CD8 + T cell response in the draining MLNs but also on previously activated CTLs in the lungs. To further explore this, we purified V-OT-I and OT-II cells and activated the transgenic CD8 + and CD4 + T cells independently in culture for 4 d, and then assessed the effect of IL-2 supplementation and/or activated CD4 + T cell addition on IL-10 production by the V-OT-I CTLs (Supplementary Fig. 10b ). Antibody-mediated TCR activation of V-OT-I alone modestly upregulated IL-2-independent expression of IL-10 ( Fig. 3d, top row) . IL-10 expression was further enhanced by the addition of exogenous IL-2 ( Fig. 3d , top row). By contrast, culture with previously activated CD8 + and CD4 + T cells resulted in robust IL-10 expression by CTLs upon TCR cross-linking (Fig. 3d , bottom row) that was inhibited by IL-2 neutralization (Fig. 3d, bottom row) . This finding supports the view that activated CD4 + T cells acting by means of IL-2 can promote the production of IL-10 by differentiated effector CD8 + T cells (CTLs). In keeping with this concept, only effector CD4 + T cells showed robust production of IL-2 (Fig. 3e) . When these in vitro-activated CD8 + CTLs were treated with IL-2 alone in short-term culture (4 h), IL-2 exposure, like TCR engagement, was able to stimulate IL-10 expression by CTLs, but the IL-2 effect was more potent when signaling in cooperation with TCR engagement (Fig. 3f) , suggesting that IL-2 can directly promote the expression of IL-10 independent of its role in promoting CTL proliferation and survival.
IL-2 signaling is required to induce IL-10 + CTLs in vivo We next assessed the contribution of CD4 + T cell-derived IL-2 and IL-2 signaling to the induction of IL-10 production by antiviral CTLs in vivo during influenza infection. We first established in vivo that CD4 + T cells were the dominant source of IL-2 (Fig. 4a,b and Supplementary Fig. 11a ) and that the depletion of CD4 + T cells abrogated most IL-2 production in both MLNs and the lung (Fig. 4c) . Furthermore, the absence of CD4 + T cells impaired IL-10 but not IL-2 production by CD8 + T cells (Supplementary Fig. 11b ), suggesting that the amount of IL-2 produced by CD8 + T cells was not sufficient to drive the maximal production of IL-10 by CTLs in vivo. In addition, transfer of wild-type (WT) CD4 + T cells but not Il2 −/− CD4 + T cells with WT CD8 + T cells into Rag2 −/− mice resulted in augmented IL-10 production by CTLs (albeit at lower levels than observed with CTLs from infected WT mice, likely owing to nonspecific homeostatic proliferation of transferred CD8 + T cells in Rag2 −/− recipients), suggesting that CD4 + T cell-derived IL-2 is required for the optimal generation of IL-10-producing CTLs in vivo (Supplementary Fig. 12 ).
In addition, we determined that IL-10-expressing CTLs in the infected lungs were IL-2Rα + (CD25 + ), indicating that they are competent for IL-2 signaling (Supplementary Fig. 13) .
To directly establish the requirement for IL-2 receptor signaling, we transferred either WT or Il2ra −/− T cells into congenic mice mismatched for the glycoprotein Thy-1 and then infected the recipient A r t i c l e s mice with influenza. Whereas transferred WT CD8 + T cells or endogenous WT CD8 + T cells produced IL-10 in the infected lungs, transferred Il2ra −/− CD8 + T cells failed to produce IL-10 during influenza infection (Fig. 4d) . We also made WT:Il2ra −/− mixed bone marrow chimeric mice and infected these mice with influenza. Il2ra −/− CTLs mounted an antigen-specific IFN-γ response that was moderately diminished compared to that in WT cells. In contrast, Il2ra −/− CTLs failed to produce IL-10 even when we accounted for the diminished proinflammatory cytokine response by normalizing the number of IL-10-producing cells to the number of antigen-specific IFN-γproducing cells (Fig. 4e,f) . By contrast, the Il2ra −/− CTLs were able to produce equivalent amounts of TNF and only slightly diminished amounts of granzyme B compared to WT CTLs in the lung ( Fig. 4f and Supplementary Fig. 14) . IL-21 is another important CD4 + T cell-derived 'helper' cytokine. However Il21r −/− CTLs were able to produce IL-10 at levels comparable to those of WT CTLs when influenza infection was carried out in the WT:Il21r −/− mixed bone marrow chimeric mice (Fig. 4g) . These data collectively demonstrate that IL-2 (rather than IL-21) is the main CD4 + T cell-derived molecule driving the development of IL-10-producing CTLs during influenza infection. Furthermore, rIL-2 administration to influenza-infected CD4 + T cell-depleted mice at the time of effector T cell infiltration into the lung-that is, 5-6 d.p.i.-enhanced the induction of IL-10 production by CTLs (Fig. 4h,i) . Taken together, these data strongly suggest that IL-2 and IL-2 receptor-dependent signaling is critical for stimulating IL-10 production by CTLs at the site of virus infection.
IL-2 and IL-27 cooperate to induce IL-10 + CTLs
Our analysis so far indicated that both CD4 + T cell-derived IL-2 and the cytokine IL-27 were necessary for the development of IL-10-producing CTLs during influenza infection. Next, we sought to determine whether IL-27 and CD4 + T cell-derived IL-2 act synergistically to activate IL-10 gene expression by CTLs. To this end, we again cultured CFSE-labeled CL-4 cells with influenza-infected DCs in the presence or absence of TS-1 cells. Inclusion of TS-1 cells or IL-27 alone in the culture enhanced the induction of IL-10-producing CTLs (Fig. 5a) . However, the presence either of TS-1 cells plus IL-27 or IL-2 plus IL-27 together in culture with the CD8 + T cells had a synergistic effect on the induction of IL-10-producing CTLs (Fig. 5a) . Likewise, the synergy between IL-27 and CD4 + T cells depended primarily on the CD4 + T cell-derived IL-2 (Fig. 5a) . Although CD4 + T cells are the main source of IL-2, CD8 + T cells are capable of producing a small amount of IL-2 during activation (Fig. 3c) . This small amount of IL-2 produced by CD8 + T cells alone was insufficient to drive the development of IL-10-producing CTLs. However, in the absence of CD4 + T cell-derived IL-2, the small amount of CTL-derived IL-2 was essential for enhancing the effect of IL-27 on induction of IL-10-producing CTLs (Fig. 5a) , suggesting that the induction of IL-10-producing CTLs by IL-27 likewise requires the presence of IL-2. The synergy between IL-27 and CD4 + T cell-derived IL-2 was also evident at the single cell level (Fig. 5b) . Furthermore, IL-27 and IL-2 acted synergistically to induce IL-10-producing CTLs in the OT-I & OT-II culture system during the initial (primary) activation ( Supplementary  Fig. 15 ) or at the effector stage (Supplementary Fig. 16) .
Having established the contribution of CD4 + T cells acting through IL-2 to stimulate IL-10 expression by CD8 + T cells, we wanted to probe the source(s) of the IL-27 in vivo. Innate immune cells in the infected lungs were the main source of IL-27 (Fig. 5c) . In this regard, it is noteworthy that neutrophils may be a principal source of IL-27. Consistent with the finding that production of IL-10 by CTLs was largely restricted to the site of infection, potential IL-27-producing cells including neutrophils and monocytes or macrophages, as well as Il27 mRNA, were enriched at the infection site compared to their abundance in the draining MLNs (Supplementary Fig. 17 ). Furthermore, CD4 + cell depletion did not affect IL-27 production in vivo (Fig. 5d) . This confirms that the impaired induction of A r t i c l e s IL-10-producing CTLs in CD4 + T cell-depleted mice was not due to the lack of IL-27. IL-27 deficiency also did not impair IL-2 production by T cells (Supplementary Fig. 18 ), suggesting that the impaired induction of IL-10-producing CTLs in IL-27-deficient mice was not due to a lack of IL-2 production. Taken together, these data demonstrate that innate cell-derived IL-27 and CD4 + T cell-derived IL-2 were independently regulated but acted in a coordinate manner to induce IL-10 production by CTLs in the respiratory tract during influenza infection.
The unexpected finding of cooperation between these two cytokines in the mouse system prompted us to investigate whether IL-2 and IL-27 likewise act cooperatively to induce IL-10 production by human CD8 + T cells. IL-2 and IL-27 cooperatively induced both Il10 mRNA expression and IL-10 protein production by CD8 + T cells ( Supplementary Fig. 19 and Fig. 5e ).
Induction of IL-10-producing CTLs require Blimp-1
To begin to define the signaling pathways within CTLs controlling the induction of IL-10 gene expression, we investigated transcription factors potentially implicated in controlling IL-10 production by CTLs. IL-10 + cells expressed higher mRNA levels of the transcriptional regulator Blimp-1 (the product of the gene Prdm1) than IL-10 − CD8 + T cells (Fig. 6a) . Blimp-1 expression is known to be induced by IL-2, and Blimp-1-deficient CD4 + T cells show comparable production of IFN-γ and IL-4 but diminished IL-10 in response to TCR stimulation 25, 26 . We therefore investigated the role of Blimp-1 in the production of IL-10 by CTLs. CD8 + T cells from infected lungs of H2-Ab1 −/− mice expressed significantly less Prdm1 and Il10 (but not Ifng or Tbx21, encoding the transcription factor T-bet) than T cells isolated from littermate controls (Fig. 6b) . Similarly, T cells from Ebi3 −/− mice expressed less Prdm1 and Il10 than controls, but comparable Ifng and Maf (Fig. 6c) . Furthermore, although exposure to either IL-2 or IL-27 was able to enhance Prdm1 expression in CTLs, simultaneous treatment of CTLs with both cytokines acted synergistically to further enhance this expression ( Fig. 6d) .
We then ectopically expressed Blimp-1 in CD8 + T cells by transducing CD8 + T cells with a Blimp-1-expressing retrovirus. Ectopic expression of Blimp-1 enhanced IL-10 production by CTLs (Fig. 6e) , although it did not induce IL-10 production by CTLs as effectively as IL-2 plus IL-27 (data not shown), suggesting that other factors may contribute to maximal IL-10 production by CTLs. We next wished to determine whether IL-2-or IL-27-induced IL-10 production by CTLs requires Blimp-1 expression by CTLs. To this end, we isolated CD8 + T cells from WT mice or mice with loxP-flanked Prdm1 selectively disrupted in T cells (Cd4-Cre Prdm1 fl/fl (Prdm1 cKO)) and stimulated them with DCs plus soluble antibody to CD3 (anti-CD3) in the absence or presence of IL-27, IL-2 or the combination of the two cytokines. CD8 + T cells lacking Blimp-1 proliferated normally but failed to produce IL-10 in response to IL-2, IL-27, or IL-2 plus IL-27 ( Fig. 6f) . Thus, IL-2-IL-27-mediated induction of IL-10 production by CTLs in vitro was Blimp-1 dependent.
The in vivo induction of IL-10 + CTLs requires Blimp-1 We next evaluated whether Blimp-1 is required for IL-10 production by CTLs in vivo. To do this, we infected Prdm1 cKO mice with influenza and at 7 d.p.i. measured IL-10 production by CTLs in the MLNs and infected lungs. Compared to CD8 + T cells from influenza-infected Blimp-1-sufficient (Cd4-cre Prdm1 fl/+ , control) mice, Blimp-1-deficient CD8 + T cells showed markedly diminished IL-10 production ( Fig. 7a,b) with comparable production of IFN-γ or TNF upon influenza infection (Fig. 7a,b) . The selective deficit in IL-10 production was also evident in bronchoalveolar lavage fluid (BALF) of the infected Prdm1 cKO mice (Fig. 7c) . The diminished release of IL-10 into the BALF probably also reflects defective IL-10 production by CD4 + T cells, as the production of IL-10 by CD4 + T cells was also impaired in Prdm1 cKO mice (data not shown). Prdm1 cKO mice also showed enhanced pulmonary inflammation in response to infection, characterized by increased infiltration of the infected lungs by mononuclear and granulocytic inflammatory cells and enhanced production of proinflammatory cytokines similar to that seen upon IL-10R blockade 6 ( Fig. 7d and Supplementary Fig. 20) . A r t i c l e s Next we sought to address whether the impaired IL-10 production by CD8 + T cells from Prdm1 cKO mice is a CD8 + T cell-intrinsic defect. We first observed that infected Prdm1 cKO mice showed amounts of IL-27 in the respiratory tract comparable to those in infected WT mice, along with moderately diminished IL-2 production as a net effect of the diminished production of IL-2 by CD4 + T cells but increased production of IL-2 by CD8 + T cells ( Supplementary  Fig. 21 and data not shown). To directly examine the role of Blimp-1 expression in regulating IL-10 production by CTLs, we transferred WT or Blimp-1-deficient T cells into Thy-1-mismatched mice and analyzed IFN-γ, TNF and IL-10 production by CTLs upon influenza infection. Transferred Blimp-1-deficient but not WT CTLs failed to produce IL-10 in response to antigenic stimulation ( Fig. 7e and  Supplementary Fig. 22 ). Together these data suggest that the regulation by Blimp-1 of IL-10 production by CTLs is cell intrinsic.
DISCUSSION
CD4 + T-cell help for CD8 + T cell responses have been previously demonstrated to be required for memory CTL formation, maintenance and recall responses [27] [28] [29] , in CTL migration to mucosal surfaces 30 and in certain experimental settings for optimum primary CTL responses to weak stimuli [31] [32] [33] . Strong inflammatory stimuli such as influenza infection, however, trigger potent primary CTL responses independent of CD4 + T cell help 19, 20 . Our results support this picture, as CD4 + T cell help was minimally required for expression of type 1 effector cytokines such as IFN-γ and cytolytic machinery such as granzyme B by CTLs in vivo. However, without CD4 + T cell help, antiviral CTL activation and differentiation is incomplete because CTLs are unable to optimally produce IL-10, a critical regulatory cytokine necessary to control excess lung inflammation during immune-mediated virus clearance 6 .
IL-2 has been shown to promote CTL memory and to support terminal effector cell differentiation by upregulating cytolytic molecules; for example, granzyme B in secondary lymphoid organs 23, 34, 35 . Our findings on the effect of defective IL-2 signaling on granzyme B expression by proliferating and/or differentiating CTLs in the draining MLNs support these earlier findings 23, 34, 35 . However, within the inflammatory milieu of the infected lungs, other signals can replace IL-2 in the induction of CTL granzyme B. Proinflammatory molecules such as type I interferons, which can induce antigen-independent granzyme B expression in CTLs within the respiratory tract 36 , may replace IL-2. By contrast we find that IL-2 has a critical nonredundant role in promoting the induction of IL-10-producing CTLs.
Here we also demonstrate a synergistic role for IL-27 in the CD4 + T cell-mediated induction of IL-10 by CTLs. Although recognized as a stimulator of type 1 helper T cell responses, IL-27 has more recently been appreciated as an important IL-10-independent and IL-10dependent regulator of host immune responses 37 -for example, CD4 + Tr1 and CD4 + effector cells induce IL-10 expression in vivo 10, 14, 15 . Our findings suggest that antiviral CTLs within the virally infected lungs are also targets of IL-27 in vivo. Although IL-27 is generally believed to be the product of activated macrophages and DCs 38 , our results suggest that neutrophils may also be an important source of IL-27 during acute respiratory viral infections. This interplay between inflammatory myeloid cell-derived IL-27 and CTL-derived IL-10 suggests a new type of regulatory loop whereby influx of inflammatory myeloid cells into the infected lungs in response to infection augments IL-10 production by CTLs responding to infection, which in turn dampens both the activation state of the innate immune cells and further infiltration of these myeloid inflammatory cells 6 .
Blimp-1 is a transcriptional repressor that functions in B cell differentiation, as well as T cell homeostasis, T effector cell differentiation and migration 39 . As previously reported 40 , Blimp-1-deficient CTLs showed a modest deficit in migration into the influenza-infected lungs, but the Blimp-1-deficient CTLs within the infected lungs showed no deficit in proinflammatory effector cytokine production. Blimp-1-deficient CTLs were, however, markedly impaired in IL-10 production, suggesting stringent requirements for Blimp-1 expression by IL-10-producing CTLs in vivo in the infected lung. Consistent with this hypothesis, IL-2-and/or IL-27-dependent IL-10 production by CTLs in vitro required that these cells express Blimp-1. Of note, both IL-10 nonproducing (IL-10 − ) and IL-10 + CTLs expressed Blimp-1, but the IL-10 + CTLs expressed two to three times as much Blimp-1. Thus a modest difference in the expression of this transcriptional regulator seems to markedly influence the ability of the activated CTLs to express the IL-10 gene, a result consistent with recently published evidence relating Blimp-1 gene dosage to CD8 + T cell exhaustion 41 . Although our findings indicate a likely nonredundant requirement for both Blimp-1 and IL-2 to generate IL-10-producing CTLs, both IL-10 + and IL-10 − CTLs express Blimp-1 and are exposed to IL-2 and IL-27 in the infected lungs. Undoubtedly other, as yet unidentified factors also affect IL-10 gene expression by CTLs in the infected respiratory tract.
In summary, we have described the cellular and molecular mechanisms controlling a regulatory cytokine production by antiviral CTLs. Our data reveal coordination between innate cell-derived signal and helper T cell-derived signal in fine-tuning the antiviral CTLs responses during acute respiratory virus infection. Our findings may provide the groundwork for future studies in manipulating IL-10 production in antiviral T cells to control excessive host inflammation during acute respiratory virus infection.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
